Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine for post-systolic thickening in stable effort angina
2015-003149-24Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ranolazine in stable angina (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Change in strain imaging post-systolic thickening. Started Jan 2021; status: completed.
02
Drugs
ranolazine
03
Conditions
stable angina
Beyond the preview
Go deeper on 2015-003149-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003149-24.